Upon the analysis of clinical characteristics among hospitalized COVID-19 patients, it was observed that rs17713054 SLC6A20-LZTFL1 (p = 0.006), rs12610495 DPP9 (p = 0.01), and rs17078346 SLC6A20-LZTFL1 (p = 0.01) were found to be linked with increased BMI (Supplementary Table S7; Figures 4A–C). Here, SLC6A20 is linked to COVID-19.